1 week Ago By ABMN Staff
Mariner LLC grew its position in shares of DaVita Inc. ( NYSE:DVA – Free Report ) by 3.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission.
The institutional investor owned 6,438 shares of the company’s stock after purchasing an additional 233 shares during the quarter. Mariner LLC’s holdings in DaVita were worth $963,000 as of its most recent SEC filing. A number of other large investors have also added to or reduced their stakes in DVA.
Te Ahumairangi Investment Management Ltd increased its stake in shares of DaVita by 1.0% in the third quarter. Te Ahumairangi Investment Management Ltd now owns 48,137 shares of the company’s stock valued at $7,846,000 after buying an additional 500 shares during the period.
Tidal Investments LLC grew its position in shares of DaVita by 45.2% during the 3rd quarter. Tidal Investments LLC now owns 5,688 shares of the company’s stock worth $932,000 after buying an additional 1,771 shares during the period.
Franklin Resources Inc. increased its stake in DaVita by 134.6% in the third quarter.
Franklin Resources Inc. now owns 54,901 shares of the company’s stock valued at $8,885,000 after purchasing an additional 31,502 shares in the last quarter. JPMorgan Chase & Co.
increased its position in DaVita by 17.8% in the 3rd quarter. JPMorgan Chase & Co.
now owns 609,076 shares of the company’s stock valued at $99,846,000 after buying an additional 92,014 shares in the last quarter. Finally, Versant Capital Management Inc increased its holdings in shares of DaVita by 58.7% during the fourth quarter.
Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after acquiring an additional 169 shares in the last quarter. Institutional investors own 90.12% of the company’s stock.
DaVita Stock Up 0.0 % DVA stock opened at $139.57 on Monday.
The stock has a 50-day simple moving average of $146.50 and a two-hundred day simple moving average of $155.24.
The firm has a market capitalization of $11.17 billion, a PE ratio of 13.00, a PEG ratio of 1.
07 and a beta of 1.04. DaVita Inc.
has a twelve month low of $131.27 and a twelve month high of $179.60.
The company has a quick ratio of 1.21, a current ratio of 1.26 and a debt-to-equity ratio of 23.
18. Wall Street Analysts Forecast Growth A number of research analysts have recently issued reports on DVA shares. StockNews.
com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday. Sanford C. Bernstein set a $184.
00 price objective on shares of DaVita in a research note on Friday, February 21st. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Barclays lifted their price target on shares of DaVita from $164.
00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company’s stock.
Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $166.33. Get Our Latest Stock Analysis on DaVita About DaVita ( Free Report ) DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. Recommended Stories Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for DaVita Inc. ( NYSE:DVA – Free Report ). Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.
com's FREE daily email newsletter ..
